Endocrinology at Ruijin Hospital Shanghai | CMCS

China's Premier Center for Diabetes, Obesity & Hormonal Disease

The Department of Endocrinology at Ruijin Hospital — affiliated with Shanghai Jiao Tong University School of Medicine — is widely recognized as one of China's finest and most research-active endocrinology centers, with a national and international reputation for excellence in diabetes, obesity, thyroid disease, adrenal disorders, and metabolic medicine. The department combines cutting-edge clinical research with outstanding patient care, offering international patients access to some of China's most distinguished endocrinologists and the latest evidence-based treatments for complex hormonal and metabolic conditions.

For international patients seeking expert endocrinology care in Shanghai — whether for difficult-to-control diabetes, obesity management, thyroid cancer, adrenal disease, or a rare endocrine condition — Ruijin Hospital's endocrinology department represents one of the most compelling destinations in Asia. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their care journey.

About the Department

Ruijin Hospital's endocrinology department is a national key clinical specialty and one of the most productive endocrinology research programs in China. The department operates a comprehensive endocrine unit encompassing dedicated inpatient wards, a diabetes management center, a thyroid disease clinic, an adrenal and pituitary disorders clinic, an obesity and metabolic surgery program, a bone metabolism service, and a PCOS and reproductive endocrinology clinic.

The department is home to the National Clinical Research Center for Metabolic Diseases — one of China's most important metabolic disease research platforms — and has been at the forefront of large-scale epidemiological studies on diabetes and obesity in China, including landmark surveys that have shaped national health policy. Faculty members publish regularly in the world's leading endocrinology and metabolism journals including New England Journal of Medicine, Lancet, Nature Medicine, Diabetes Care, and Journal of Clinical Endocrinology & Metabolism.

Conditions Treated

• Type 2 Diabetes — Comprehensive management including the latest pharmacotherapy (SGLT2 inhibitors, GLP-1 receptor agonists, dual GIP/GLP-1 agonists), advanced insulin regimens, CGM, and closed-loop systems
• Type 1 Diabetes — Insulin pump therapy (CSII), CGM, hybrid closed-loop systems, and islet transplantation evaluation
• Difficult-to-Control & Brittle Diabetes — Specialist management of patients with recurrent hypoglycemia, hypoglycemia unawareness, and extreme glycemic variability
• Diabetic Complications — Diabetic nephropathy, retinopathy, neuropathy, and cardiovascular disease; multidisciplinary complication management
• Obesity & Metabolic Syndrome — Medical weight management with semaglutide and tirzepatide; metabolic surgery (sleeve gastrectomy, gastric bypass) in collaboration with surgery
• Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) — Integrated metabolic management with hepatology
• Thyroid Nodules & Cancer — Ultrasound-guided FNA, molecular testing, thyroidectomy coordination, radioiodine therapy, and targeted therapy for advanced thyroid cancer
• Hypothyroidism & Hyperthyroidism — Graves' disease, Hashimoto's thyroiditis, and subclinical thyroid dysfunction
• Cushing's Syndrome — Comprehensive evaluation including dynamic testing, inferior petrosal sinus sampling (IPSS), and multidisciplinary treatment planning
• Primary Aldosteronism — Adrenal vein sampling (AVS) for lateralization; medical and surgical management
• Pheochromocytoma & Paraganglioma — Biochemical diagnosis, imaging localization, and surgical coordination
• Adrenal Insufficiency — Primary (Addison's disease) and secondary adrenal insufficiency; glucocorticoid replacement optimization
• Acromegaly & Pituitary Tumors — Somatostatin analogues, pegvisomant, and surgical/radiation coordination; prolactinoma and non-functioning adenoma management
• Osteoporosis & Metabolic Bone Disease — DEXA scanning, fracture risk assessment, and the full range of anti-osteoporosis therapies including romosozumab
• PCOS & Reproductive Endocrinology — Hormonal management, insulin sensitization, and fertility coordination
• Multiple Endocrine Neoplasia (MEN) — MEN1 and MEN2 syndrome management with genetic counseling
• Rare Endocrine Disorders — Congenital adrenal hyperplasia, autoimmune polyglandular syndromes, and other rare hormonal conditions

Leading Specialists

Prof. Ning Guang (宁光) — Academician, Chinese Academy of Sciences

Prof. Ning Guang is one of China's most eminent endocrinologists and a nationally recognized authority in diabetes, obesity, and metabolic disease. Elected as an Academician of the Chinese Academy of Sciences, Prof. Ning has led landmark epidemiological studies on diabetes prevalence in China — including studies published in the New England Journal of Medicine that revealed the staggering scale of China's diabetes epidemic and shaped national health policy. As a former director of Ruijin Hospital's endocrinology department, he has built one of China's most productive endocrinology research and clinical programs. His research spans diabetes genetics, metabolic surgery outcomes, and novel therapeutic targets for obesity and type 2 diabetes.

Prof. Wang Weiqing (王卫庆) — Director, Endocrinology

Prof. Wang Weiqing is a leading endocrinologist with particular expertise in adrenal disorders, pituitary disease, and endocrine hypertension. As Director of the Department of Endocrinology at Ruijin Hospital, she oversees one of China's most comprehensive endocrine programs. Prof. Wang is nationally recognized for her expertise in primary aldosteronism — including adrenal vein sampling (AVS) for lateralization, a technically demanding procedure essential for surgical decision-making — and in Cushing's syndrome evaluation including inferior petrosal sinus sampling (IPSS). Her research on adrenal disorders and endocrine hypertension has been published in leading international endocrinology journals.

Prof. Gao Xin (高鑫) — Metabolic Disease & NAFLD

Prof. Gao Xin is a distinguished endocrinologist with particular expertise in metabolic syndrome, non-alcoholic fatty liver disease (NAFLD/NASH), and the intersection of metabolic and cardiovascular disease. Her research on NAFLD epidemiology, pathogenesis, and treatment has been published in leading journals and has contributed significantly to the understanding of metabolic liver disease in China. Prof. Gao leads an integrated metabolic disease program that addresses the complex interplay between obesity, insulin resistance, dyslipidemia, and liver disease.

Prof. Li Xiaoying (李小英) — Diabetes & Thyroid Disease

Prof. Li Xiaoying is a leading endocrinologist with expertise in diabetes management, thyroid disease, and reproductive endocrinology. She is particularly recognized for her work on the relationship between thyroid function and metabolic disease, and for her contributions to the management of thyroid disorders in pregnancy. Her clinical program provides expert care for patients with complex thyroid conditions including thyroid cancer, Graves' disease, and thyroid dysfunction in the context of metabolic disease.

National Clinical Research Center for Metabolic Diseases

Ruijin Hospital hosts the National Clinical Research Center for Metabolic Diseases — one of China's most important platforms for metabolic disease research and clinical translation. The center coordinates multi-center clinical trials, epidemiological studies, and translational research across diabetes, obesity, thyroid disease, and metabolic bone disease. For international patients, this means access to cutting-edge clinical trials evaluating novel therapies not yet widely available, as well as the most up-to-date evidence-based treatment protocols.

Diabetes Technology Program

Ruijin's diabetes technology program is one of the most advanced in China, offering the full range of modern diabetes management technologies:

• Continuous Glucose Monitoring (CGM) — Real-time and flash CGM for glycemic optimization and hypoglycemia detection
• Insulin Pump Therapy (CSII) — Continuous subcutaneous insulin infusion for type 1 and selected type 2 diabetes patients
• Hybrid Closed-Loop Systems — Artificial pancreas technology for eligible patients
• Advanced Insulin Regimens — Ultra-long-acting insulins (degludec, glargine U300), ultra-rapid insulins, and combination injectable therapy
• Structured Diabetes Education — Individualized education programs covering self-management, carbohydrate counting, and technology use

Obesity & Metabolic Surgery Program

Ruijin Hospital's obesity program is one of the most comprehensive in Shanghai, combining medical weight management with metabolic surgery for eligible patients:

• Medical Weight Management — GLP-1 receptor agonists (semaglutide), dual GIP/GLP-1 agonists (tirzepatide), and combination pharmacotherapy
• Metabolic Surgery — Laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass in collaboration with general surgery; pre- and post-operative endocrine management
• Post-Bariatric Endocrine Care — Management of post-surgical hypoglycemia, nutritional deficiencies, and metabolic outcomes

Why International Patients Choose Ruijin Endocrinology

• National Research Leadership — Home to the National Clinical Research Center for Metabolic Diseases; landmark publications in NEJM, Lancet, and Nature Medicine
• Academician-Led Program — Department built by Prof. Ning Guang, Academician of the Chinese Academy of Sciences
• Adrenal & Pituitary Expertise — AVS and IPSS capabilities for precise diagnosis of primary aldosteronism and Cushing's syndrome
• Advanced Diabetes Technology — Full range of CGM, insulin pump, and closed-loop systems
• Comprehensive Obesity Program — Medical and surgical weight management with expert post-bariatric endocrine care
• Cost-Effectiveness — World-class endocrinology care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your endocrine history, recent blood tests, imaging reports, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate endocrinologist based on your condition — diabetes, obesity, thyroid, adrenal, pituitary, or bone metabolism.
4. Priority Scheduling — We secure a consultation with minimal waiting time.
5. Travel & Logistics — Assistance with visa invitation letters, accommodation near Ruijin Hospital, and Shanghai airport transfers.
6. On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication.
7. Diagnostic Support — Full coordination of dynamic endocrine function tests, imaging, CGM setup, and other required investigations.
8. Post-Consultation Follow-Up — Laboratory result translation, treatment plan interpretation, and remote follow-up coordination after you return home.

Book a Consultation

If you are seeking expert endocrinology care in Shanghai — whether for diabetes, obesity, thyroid disease, adrenal or pituitary disorders, or a rare endocrine condition — CMCS can arrange a specialist consultation with Ruijin Hospital's endocrinology team.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com